XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort (XVU-AV DAPT)
This study has been completed.
Harvard Clinical Research Institute
Eli Lilly and Company
Daiichi Sankyo Inc.
Information provided by (Responsible Party):
First received: April 16, 2010
Last updated: April 8, 2015
Last verified: April 2015
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||July 2013|
|Primary Completion Date:||February 2013 (Final data collection date for primary outcome measure)|
|Certification or Request for Extension to Delay Results Received:||January 20, 2015|